Call for proposals for personalising health and care H2020-PHC-2014-single-stage Closed!

Objectives

The Framework Programme for Research and Innovation (2014-2020) is implemented by specific programme and work programmes.

The “Societal challenges” responds directly to the policy priorities and societal challenges that are identified in the Europe 2020 strategy and that aim to stimulate the critical mass of research and innovation efforts needed to achieve the Union's policy goals.

The specific objective is to fully exploit the potential of Europe's talent pool and to ensure that the benefits of an innovation-led economy are both maximised and widely distributed across the Union in accordance with the principle of excellence.

Funding shall be focused on the following specific objectives:
(a) Health, demographic change and well-being.
(b) Food security, sustainable agriculture and forestry, marine, maritime and inland water research. and the bioeconomy.
(c) Secure, clean and efficient energy.
(d) Smart, green and integrated transport.
(e) Climate action, environment, resource efficiency and raw materials.
(f) Europe in a changing world - Inclusive, innovative and reflective societies.
(g) Secure societies - Protecting freedom and security of Europe and its citizens.

Actions

Actions foreseen within this call for proposals include the following topics:

  • PHC-07-2014: Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens. Human and animal health worldwide is increasingly threatened by potential epidemics caused by existing, new and emerging infectious diseases (including from antimicrobial resistant pathogens), placing a burden on health and veterinary systems, reducing consumer confidence in food, and negatively affecting trade, food chain sustainability and food security. The increasing incidence and more rapid spread of such diseases are facilitated by modern demographic, environmental, technological, economic and societal conditions. Many of these infections are zoonoses, necessitating an integrated, cross-border, ‘one health’ approach to research and public health measures in the human and veterinary field, including the food chain.
  • PHC-08-2014: Vaccine development for poverty-related and neglected infectious diseases: tuberculosis. Vaccines offer a safe and cost-effective way to protect large populations against infectious diseases, or at least to mitigate the clinical course of these diseases. Yet many poverty-related and neglected infectious diseases continue to escape attempts to develop effective vaccines against them. Disappointing results of recent clinical trials point to bottlenecks in identifying viable candidate vaccines, which if unaddressed will continue to present significant risks of failure at relatively late stages of the development process. The specific challenge will be to shift this ‘risk curve’ in order better to select successful vaccine candidates (and discard those with a higher risk of failure) at an earlier stage of the vaccine development process.
  • PHC-15-2014: Clinical research on regenerative medicine. Translating basic knowledge on regenerative medicine into the clinic is held up by the difficulty in undertaking ‘first in man’ studies. Specific research is needed for proving safety, efficacy and repeatability of new treatments. The, very often iterative, dialogue between the relevant authorities and those developing regenerative medicine approaches is needed before specific regulatory requirements can be established. As a new therapeutic field lacking established business models, financing is a particular obstacle to clinical-stage research in regenerative medicine. The challenge is to initiate a specific action to overcome this hurdle to in-patient research and to determine the potential of new regenerative therapies.
  • PHC-19-2014: Advancing active and healthy ageing with ICT: service robotics within assisted living environments. Citizens in an ageing European population are at greater risk of cognitive impairment, frailty and social exclusion with considerable negative consequences for their independence, quality of life, that of those who care for them, and for the sustainability of health and care systems. The challenge is to develop new breakthroughs for active and assisted living based on advanced ICT solutions.
  • PHC-26-2014: Self management of health and disease: citizen engagement and Health. Empowering citizens to manage their own health and disease will result in more cost-effective healthcare systems by improving utilisation of healthcare, enabling the management of chronic diseases outside institutions, improving health outcomes, and by encouraging healthy citizens to remain so. Several clinical situations would be prevented or better monitored and managed with the participation of the patient him or herself. Care sciences may complement the medical perspective without increasing the cost. This requires research into socio-economic and environmental factors, dietary impact and cultural values, behavioural and social models, attitudes and aspirations in relation to personalised health technologies, mobile and/or portable and other new tools, co-operative ICTs, new diagnostics, sensors and devices (including software) for monitoring and personalised services and interventions which promote a healthy lifestyle, wellbeing, mental health, prevention and self-care, improved citizen/healthcare professional interaction and personalised programmes for disease management. Support for knowledge infrastructures is also required, as well as the combination of predictive personalised models with personal health systems and other sources of data.
  • PHC-31-2014: Foresight for health policy development and regulation. The complex interactions between multiple determinants of health and wellbeing are not well understood. These include but are not limited to air quality, climate change, traffic and congestion, ambient noise, built environment, urban sprawl, sustainable food systems, waste, lifestyle, behaviour, occupation, demographic change, cultural characteristics, socio-economic factors, globalisation of exchanges of goods and people and so on. Adding to the complexity, currently used measures and indicators of health status and quality of life are inadequate to capture the effect of these interactions and there is a lack of comparable health related data as produced by different health information systems. Furthermore, the co-existence of a multitude of analytical frameworks, often not multi-factorial in nature, limits the comprehensiveness of the assessment.
  • PHC-20-2014: Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment. Citizens in an ageing European population are at greater risk of cognitive impairment, frailty and social exclusion with considerable negative consequences for their independence, quality of life, that of those who care for them, and for the sustainability of health and care systems. The challenge is to deploy innovative and user led ICT pilot projects in support of independent living with cognitive impairments and translate promising results into scalable practice across Europe.
  • PHC-34-2014: eHealth interoperability. There are a number of challenges to effective eHealth service deployment in Europe, each of which is to be addressed by an individual Co-ordination and Support Action as below. - There is little stakeholder consensus on a common reference information model for eHealth deployment in Europe, and it seems unlikely that international consensus can be reached for common (clinical) reference standards in a reasonable timeframe and budget. It is therefore reasonable to ask whether competing / overlapping standards can co-exist in a common eHealth European interoperability framework; this is of relevance to the MoU on eHealth between the EC and the US department of Health and Human services. - The Directive on patients' rights in cross-border healthcare (Directive 2011/24/EU) pursues the objective to enhance safety and continuity of cross-border treatment through interoperable access to patients' summary data and interoperable ePrescriptions. The challenge in ePrescription is how medicines can be communicated in the cross border setting. There is neither a common data model nor a common vocabulary for medicinal or pharmaceutical products throughout Europe. - The clinical domain is probably among the most complex from a semantic point of view. Vocabularies, terminologies, classification and coding systems, and ontologies have been developed by different stakeholders to address different needs in different subdomains. The semantic health report had already demonstrated the central role that SNOMED CT could play as a core terminology to solve semantic interoperability issues, provided that "evidence-based results of SNOMED CT’s fitness for purpose are assessed". The epSOS pilot project has retained SNOMED CT as one of the constituents of its master value sets catalogue which ensures semantic interoperability across the borders in the frame of the pilot. More recently, the eHealth Network called on the Commission to play a more active role in assessing the value of SNOMED CT for eHealth deployments in Europe. A detailed analysis on the advantages and disadvantages, as well as the impact of using SNOMED CT as the core terminology at the EU level is needed. - The Connecting Europe Facility will provide the funding and the governance framework to deploy cross border eHealth Services, among other digital services, until 2020. The intention is to migrate progressively the Connecting Europe facility from a publicly funded initiative to a self-financed operation. There is a need to identify the right business model and plan which would identify sustainable sources of revenue and all the costs which the operations of such services would generate. Gathering evidence that interoperability contributes to lowering the cost of health systems is an important element for decision makers when they have to envisage eHealth investments.

European community funding

The Community provisional funding available for the call for proposals is:

  • 185,20 Million EUR (Global Budget)

All the important deadlines

  • 15 April 2014 - 5 years ago (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Personalising health and care (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes